Peter Reiss Selected Research

Anti-HIV Agents (AIDS Drugs)

10/2019	Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
8/2019	Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study.
1/2019	Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.
11/2017	Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
1/2016	An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
1/2016	Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
1/2016	Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.
3/2013	Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
10/2012	Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
10/2010	Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Reiss Research Topics

Disease

61	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 07/2002
30	Infections 06/2021 - 07/2002
29	HIV Infections (HIV Infection) 06/2022 - 08/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2002
14	Viremia 01/2022 - 05/2008
14	Hypertension (High Blood Pressure) 10/2018 - 05/2003
13	Myocardial Infarction 01/2018 - 11/2003
13	Lipodystrophy 10/2012 - 07/2002
12	Inflammation (Inflammations) 01/2021 - 04/2009
9	Neoplasms (Cancer) 01/2021 - 06/2010
9	Cognitive Dysfunction 01/2020 - 01/2016
9	Insulin Resistance 11/2016 - 02/2003
7	Coinfection 07/2020 - 08/2008
6	Hepatitis B 01/2019 - 08/2008
6	Tuberculosis (Tuberculoses) 01/2019 - 12/2005
5	Dyslipidemias (Dyslipidemia) 10/2021 - 04/2007
5	Chronic Renal Insufficiency 10/2019 - 07/2010
5	Coronary Disease (Coronary Heart Disease) 12/2014 - 05/2003
5	Diabetes Mellitus 10/2012 - 05/2003
4	Frailty 01/2021 - 01/2016
4	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021 - 08/2002
4	Stroke (Strokes) 08/2019 - 01/2013
4	Hepatitis C 01/2019 - 01/2005
4	Disease Progression 07/2014 - 09/2007
3	Immune Reconstitution Inflammatory Syndrome 12/2019 - 08/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2016
3	Fibrosis (Cirrhosis) 01/2019 - 07/2012
3	Opportunistic Infections (Opportunistic Infection) 03/2016 - 08/2002
3	Osteoporosis 11/2015 - 02/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 12/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 03/2009
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020 - 01/2016
2	AIDS Dementia Complex 01/2018 - 03/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2017 - 01/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 07/2012
2	Metabolic Bone Diseases (Osteopenia) 11/2015 - 02/2015
2	Renal Insufficiency (Renal Failure) 07/2012 - 07/2002
2	Body Weight (Weight, Body) 07/2010 - 05/2003
2	Atherosclerosis 06/2010 - 07/2007
2	Hypertriglyceridemia 06/2010 - 01/2006
2	Hypersensitivity (Allergy) 08/2009 - 03/2008
2	Nephrolithiasis 06/2006 - 07/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2003 - 02/2003

Drug/Important Bio-Agent (IBA)

22	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2003
20	Pharmaceutical PreparationsIBA 10/2021 - 07/2002
14	Anti-HIV Agents (AIDS Drugs)IBA 10/2019 - 02/2009
12	LipidsIBA 01/2016 - 07/2002
11	Protease Inhibitors (Protease Inhibitor)IBA 10/2019 - 07/2002
10	Reverse Transcriptase InhibitorsIBA 01/2018 - 02/2003
10	Ritonavir (Norvir)FDA Link 01/2018 - 05/2003
9	abacavir (Ziagen)FDA Link 10/2021 - 07/2004
8	NucleosidesIBA 01/2018 - 02/2003
8	Lamivudine (Epivir)FDA Link 01/2013 - 07/2007
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2008
7	Tenofovir (Viread)FDA Link 07/2020 - 04/2012
7	Triglycerides (Triacylglycerol)IBA 01/2017 - 02/2003
6	Lopinavir FDA Link 10/2021 - 02/2010
6	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 01/2013
6	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2005
6	Stavudine (Zerit)FDA LinkGeneric 01/2016 - 06/2004
6	CholesterolIBA 01/2014 - 02/2003
6	Zidovudine (Retrovir)FDA LinkGeneric 04/2012 - 06/2004
6	Nevirapine (Viramune)FDA Link 02/2010 - 07/2002
5	Indinavir (Crixivan)FDA Link 10/2021 - 07/2002
5	CreatinineIBA 01/2017 - 06/2006
5	Mitochondrial DNA (mtDNA)IBA 01/2012 - 06/2004
4	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2012
4	Didanosine (Videx)FDA LinkGeneric 01/2016 - 09/2007
4	HDL CholesterolIBA 07/2011 - 02/2003
4	Lipoproteins (Lipoprotein)IBA 06/2010 - 07/2002
3	Darunavir (Prezista)FDA Link 10/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 06/2021 - 01/2008
3	AntigensIBA 01/2020 - 04/2009
3	Alanine Transaminase (SGPT)IBA 01/2019 - 02/2013
3	C-Reactive ProteinIBA 01/2019 - 04/2009
3	HIV Protease InhibitorsIBA 01/2018 - 01/2006
3	insulin receptor-related receptor (IRR)IBA 01/2012 - 01/2008
2	Integrase InhibitorsIBA 01/2021 - 12/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 05/2008
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2016
2	Biological ProductsIBA 01/2020 - 01/2019
2	dolutegravirIBA 10/2019 - 01/2015
2	Lipopolysaccharide ReceptorsIBA 01/2019 - 12/2017
2	efavirenz (Sustiva)FDA Link 01/2018 - 10/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 12/2015
2	Emtricitabine (Emtriva)FDA Link 11/2017 - 04/2012
2	Retinaldehyde (Retinal)IBA 03/2016 - 01/2016
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2016 - 05/2008
2	Nelfinavir (Viracept)FDA Link 01/2016 - 09/2007
2	Surface Antigens (Surface Antigen)IBA 11/2015 - 03/2013
2	N-acetoacetyl-N-deacetylcolchicineIBA 04/2015 - 10/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2013 - 01/2013
2	LDL CholesterolIBA 06/2010 - 02/2003
2	Insulin (Novolin)FDA Link 02/2010 - 11/2009
2	Glucose (Dextrose)FDA LinkGeneric 11/2009 - 01/2008

Therapy/Procedure

67	Therapeutics 06/2022 - 07/2002
60	Highly Active Antiretroviral Therapy (HAART) 11/2021 - 07/2002
18	Art Therapy 06/2022 - 01/2008
2	Liver Transplantation 01/2019 - 01/2016
2	Ambulatory Care (Outpatient Care) 01/2016 - 01/2013